Publications (14)

2020

  1. Use of thrombopoietin receptor agonists for immune thrombocytopenia in pregnancy: Results from a multicenter study

    Blood, Vol. 136, Núm. 26, pp. 3056-3161

  2. Use of eltrombopag for patients 65 years old or older with immune thrombocytopenia

    European Journal of Haematology, Vol. 104, Núm. 3, pp. 259-270

  3. Risk of COVID-19 in oncohematological patients

    American journal of blood research, Vol. 10, Núm. 3, pp. 52-53

2019

  1. Updated international consensus report on the investigation and management of primary immune thrombocytopenia

    Blood Advances, Vol. 3, Núm. 22, pp. 3780-3817

  2. Multirefractory primary immune thrombocytopenia; targeting the decreased sialic acid content

    Platelets, Vol. 30, Núm. 6, pp. 743-751

  3. Management of adult patients with primary immune thrombocytopenia (itp) in clinical practice: A consensus approach of the Spanish itp expert group

    Advances in Hematology, Vol. 2019

  4. Identification of 58 mutations (26 Novel) in 94 of 109 symptomatic Spanish probands with protein C deficiency

    Thrombosis and Haemostasis, Vol. 119, Núm. 9, pp. 1409-1418

  5. Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopenia

    Scientific Reports, Vol. 9, Núm. 1

2018

  1. Unraveling the heterogeneity of IgM monoclonal gammopathies: a gene mutational and gene expression study

    Annals of Hematology, Vol. 97, Núm. 3, pp. 475-484

  2. A new prognostic model identifies patients aged 80 years and older with diffuse large B-cell lymphoma who may benefit from curative treatment: A multicenter, retrospective analysis by the Spanish GELTAMO group

    American Journal of Hematology, Vol. 93, Núm. 7, pp. 867-873

2017

  1. Use of eltrombopag for secondary immune thrombocytopenia in clinical practice

    British Journal of Haematology, Vol. 178, Núm. 6, pp. 959-970

  2. Efficacy and safety of eltrombopag in persistent and newly diagnosed ITP in clinical practice

    International Journal of Hematology, Vol. 106, Núm. 4, pp. 508-516

  3. Development and validation of a new questionnaire measuring treatment satisfaction in patients with non-valvular atrial fibrillation: SAFUCA®

    Quality of Life Research, Vol. 26, Núm. 3, pp. 767-778

  4. Characteristics and management of primary and other immune thrombocytopenias: Spanish registry study

    Hematology, Vol. 22, Núm. 8, pp. 484-492